These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 14511197)
1. Glycometabolic status and acute myocardial infarction: has the time come for glucose-insulin-(potassium) therapy? Wong V; Cheung NW; Boyages SC Intern Med J; 2003; 33(9-10):443-9. PubMed ID: 14511197 [TBL] [Abstract][Full Text] [Related]
2. Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial. Apstein CS JAMA; 2005 Jun; 293(21):2596-7; author reply 2598. PubMed ID: 15928276 [No Abstract] [Full Text] [Related]
3. Glucose-insulin-potassium therapy in the era of coronary revascularization. Leos CL; Griego JE; Anderson JR Cardiol Rev; 2005; 13(5):266-70. PubMed ID: 16106190 [TBL] [Abstract][Full Text] [Related]
4. Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial. Dey J; Blonde L; Burshell A; Bolton P; Richard A JAMA; 2005 Jun; 293(21):2597-8; author reply 2598. PubMed ID: 15928277 [No Abstract] [Full Text] [Related]
5. High-dose glucose-insulin-potassium treatment reduces myocardial apoptosis in patients with acute myocardial infarction. Zhang L; Zhang L; Li YH; Zhang HY; Chen ML; Gao MM; Hu AH; Yang HS; Yang HS Eur J Clin Invest; 2005 Mar; 35(3):164-70. PubMed ID: 15733070 [TBL] [Abstract][Full Text] [Related]
19. [Therapy with glucose-insulin-potassium reduces the complications in the acute phase of myocardial infarct. Arguments in favor]. Alegría Ezquerra E; Maceria González A Rev Esp Cardiol; 1998 Sep; 51(9):720-6. PubMed ID: 9803797 [TBL] [Abstract][Full Text] [Related]
20. [Is justified the use of GIK solutions in acute myocardial infarct?]. de Micheli A Arch Cardiol Mex; 2008; 78(3):243-6. PubMed ID: 18959010 [No Abstract] [Full Text] [Related] [Next] [New Search]